Ovid Therapeutics' Series A Round

Ovid Therapeutics raised a round of funding on October 10, 2014. Investors include DoubleLine Equity Healthcare Fund.

Ovid Therapeutics (NASDAQ: OVID) is a New York-based biopharmaceutical company using its BoldMedicine approach to develop therapies that transform the lives of patients with rare neurological diseases…

Articles about Ovid Therapeutics' Series A Round: